Header Logo

WEN-JEN HWU

Concepts (494)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with WEN-JEN HWU's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that WEN-JEN HWU has written about over time.
Antineoplastic Agents, Alkylating, 8 publications between 1997 and 2016, average publication date September 2004. Dacarbazine, 25 publications between 1997 and 2017, average publication date November 2006. Recombinant Proteins, 13 publications between 1996 and 2018, average publication date March 2008. Interferon-alpha, 14 publications between 1995 and 2018, average publication date December 2008. Antineoplastic Combined Chemotherapy Protocols, 29 publications between 1995 and 2020, average publication date April 2009. Interleukin-2, 9 publications between 1995 and 2018, average publication date May 2009. Neoplasm Metastasis, 22 publications between 1996 and 2019, average publication date June 2010. Antineoplastic Agents, 33 publications between 1996 and 2017, average publication date January 2011. Brain Neoplasms, 15 publications between 2001 and 2019, average publication date February 2011. Melanoma, 120 publications between 1993 and 2024, average publication date August 2011. Skin Neoplasms, 60 publications between 1995 and 2024, average publication date February 2012. Clinical Trials as Topic, 7 publications between 1997 and 2020, average publication date May 2012. Antibodies, Monoclonal, 17 publications between 2003 and 2017, average publication date March 2013. Immunotherapy, 13 publications between 2000 and 2019, average publication date February 2016. Antibodies, Monoclonal, Humanized, 20 publications between 2003 and 2020, average publication date June 2016. Ipilimumab, 13 publications between 2011 and 2020, average publication date June 2016. Programmed Cell Death 1 Receptor, 18 publications between 2012 and 2021, average publication date February 2017. CTLA-4 Antigen, 9 publications between 2011 and 2021, average publication date August 2017. Antineoplastic Agents, Immunological, 8 publications between 2017 and 2020, average publication date April 2018. Drug-Related Side Effects and Adverse Reactions, 3 publications between 2017 and 2020, average publication date March 2019.

To see the data from this visualization as text, click here.
HWU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (494)
Explore
_
Co-Authors (98)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_